Skip to main content

Author: Bill Snyder

Harvard’s Seidman to speak at VU

Mar. 7, 2013—Jonathan Seidman, Ph.D., who has made pivotal contributions to understanding the genetic basis of cardiomyopathy and other heart diseases, will deliver the next Flexner Discovery Lecture on Thursday, March 14.

Read more

Gene ‘dose’ may be key to autism

Mar. 4, 2013—Individuals with overexpression of the gene MECP2 have core features of autism spectrum disorder.

Read more

Potent genetic risk factor for breast cancer identified

Feb. 28, 2013—Researchers at Vanderbilt University have found a powerful new genetic risk factor for breast cancer.

Read more

Institute of Chemical Biology to celebrate 10th anniversary

Feb. 28, 2013—Top chemists from around the country will be on hand March 12 to celebrate the 10th anniversary of the Vanderbilt Institute of Chemical Biology (VICB), a brave experiment that helped jumpstart the University’s robust drug discovery initiative.

Read more

Discovery Lecture explores brain’s sensitivity to insulin

Feb. 28, 2013—Diabetes has a big impact on the brain.

Read more

Series of events explore brain disorders, neuroscience research

Feb. 21, 2013—“Brain Blast,” a half-day of free, hands-on activities for children and adults will be held from 9 a.m. to 1 p.m., Saturday, March 2, at Vanderbilt Health One Hundred Oaks.

Read more

Cure in sight for kissing bug’s bite

Feb. 15, 2013—It’s possible to cure Chagas disease – a deadly tropical infection transmitted by “kissing bugs” – in a mouse model.

Read more

Vaccination still key defense as flu season continues

Feb. 14, 2013—As is the case throughout the country, this year’s flu season in Middle Tennessee is hitting elderly people particularly hard.

Read more

Harvard’s Kahn set for Discovery Lecture

Feb. 14, 2013—C. Ronald Kahn, M.D., renowned for his contributions to the field of insulin signaling and its role in type 2 diabetes and obesity, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 21.

Read more

VU, GlaxoSmithKline team to develop novel treatments for severe obesity

Feb. 11, 2013—Vanderbilt University has signed a collaboration agreement with GlaxoSmithKline (GSK) for the discovery, development and commercialization of novel therapies for severe obesity.

Read more

Humble yeast helps predict how genes are regulated

Feb. 7, 2013—Budding yeast occupies a place of honor in the pantheon of human history. Saccharomyces cerevisiae has been used for baking and alcoholic fermentation for thousands of years.

Read more

For people with ASD, adulthood no easy transition

Feb. 7, 2013—One of the critical, unmet needs for people with autism spectrum disorder (ASD) is support for the transition into adulthood.

Read more

Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
VUMC Voice